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The density, sound velocity and viscosity of doxycycline hyclate in water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine have been determined at different temperatures (305.15, 310.15, 315.15 and 320.15) K. 
The calculated values of partial molar volume (Vϕ
o ), standard partial molar volume of transfer (Δtr Vϕ
o ), partial molar 
adiabatic compressibility (κϕ,s
o ) and partial molar adiabatic compressibility of transfer (Δtr κϕ,s
o ) for doxycycline hyclate in 
water, aqueous solution of L-phenylalanine and aqueous solution of glycyl glycine infer the dominance of ion-hydrophilic 
interactions over hydrophobic-hydrophobic interactions. The Jones-Dole viscosity B-coefficient, viscosity B-coefficient of 
transfer (ΔtrB), free energy of activation of viscous flow per mole of pure solvent (Δμ
1
o∗) and solute  Δμ
2
o∗ , respectively, 
activation entropy (ΔS2
o∗) and activation enthalpy (ΔH2
o∗) of doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl glycine also have been calculated using viscosity data. The structure making 
and breaking behaviour of doxycycline hyclate in water, aqueous solution of L-phenylalanine and aqueous solution of glycyl 








). The presence and absence of caging effect has 
been studied with the help of partial molar adiabatic expansibility (Eϕ
o ). The isobaric thermal expansion coefficient  




o), intermolecular free length and acoustic impedance for doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl glycine also have been determined. 
Keywords: Jones-Dole B-coefficient, Partial molar volume, Partial molar adiabatic compressibility, Standard partial molar 
volume of transfer, Transition state theory, Walden Product 
Proteins play vital role in regulating the system of 
human body. They accelerate different biological 
reactions and thus proteins are important for various 
physiologic functions of life. Proteins also serve as 
host for different prescribed drugs
1-2
 and binding of 
drugs to proteins is the foremost action during drug 
delivery. The knowledge of drug-protein binding 
phenomenon is vital for understanding the 
transportation and action of drug. However proteins 
are biological polymers having various folds, loops 
and curves in their structures. Due to twisting of 
polypeptide chains proteins have 3D shape. Thus 
straight forward investigation of molecular 
interactions between drugs and proteins is not 
practicable. The long chains in proteins are composed 
of amino acid residues and peptides
3-5
. Therefore 
amino acids and peptides serve as fairly appropriate 
and convenient tool to disclose the salient aspects of 
drug-protein binding indirectly. Thus the drug-amino 
acid interactions are of immense importance in 
pharmaceutical and medicinal chemistry
6-7
. These 




Doxycycline hyclate is a very commonly used 
tetracycline antibiotic drug for the treatment of all 
type of bacterial infections. L-phenylalanine is 
essential amino acid and it occurs in protein rich 
food
14-16
. It is very effective in the treatment of 
attention deficit-hyperactivity disorder, Parkinson's 
disease, osteoarthritis, rheumatoid arthritis and 
vitiligo. The glycyl glycine is the simplest dipeptide 
containing two glycine molecules joined by single 
peptide bond. It has low toxicity and it is used as 
buffer for biological systems. The amphiprotic 
character is imparted due to carboxylic acid and 
amine functional groups in amino acids as well as 
dipeptides. Thus both, neutral and zwitterionic forms 
of L-phenylalanine and glycyl glycine exist in 






. The side chain of L-phenylalanine 
contains non polar bulky benzyl group and that of 
glycyl glycine contains hydrogen atoms.  
The volumetric, ultrasonic and viscometric 
properties of drug doxycycline hyclate in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine have been studied. These 
properties rely on molecular size, structure, chain 
length and various interactions operating in the 
solutions. Therefore various volumetric, ultrasonic 
and viscosity parameters are used to obtain  
valuable information about interactions occurring 
between solute-solute molecules and solute-solvent  
molecules in different solution
18-21
. The variation in 
concentration and temperature has significant impact 
on the intermolecular interactions
22-26
, thus density, 
sound velocity and viscosity have been measured by 
using variable concentrations of drug as well as amino 
acids at different temperatures ranging from (305.15, 
310.15, 315.15 and 320.15) K.  
 
Materials and Methods 
Doxycycline hyclate (Alfa Aesar), L-phenylalanine 
(SDFCL) and glycyl glycine (LOBA Chemie 
Mumbai) with mass purity ≥ 99.0% have been used in 
the present study. The other details of chemicals along 
with their structures are shown in Table 1. 
To analyze drug-water interactions and influence of 
L-phenylalanine and glycyl glycine on these 
interactions, (0.002 to 0.01) mol kg
−1
 doxycycline 
hyclate have been studied in water, (0.002, 0.004 and 
0.006) mol kg
−1
aqueous solution of L-phenylalanine 
and (0.002, 0.004 and 0.006) mol kg
−1
aqueous 
solution of glycyl glycine. The different solutions 
have been prepared by weight method in triple 
distilled water having very low specific conductance 
and weight measurements are performed in Shimadzu 
electronic balance.  
For measuring density and sound velocity of 
doxycycline hyclate in water, (0.002, 0.004 and 
0.006) mol kg
−1
 aqueous solution of L-phenylalanine 
and (0.002, 0.004 and 0.006) mol kg
−1
 aqueous 
solution of glycyl glycine, DSA 5000 i.e. density and 
sound analyser, Anton Paar has been used. The 
jacketed Ostwald viscometer has been used to 
measure the time of flow of doxycycline hyclate in 
water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine. The outer jacket in 
viscometer helps in proper circulation of solution to 
maintain constant temperature. The calibration of 
densimeter has been done by using triple distilled and 
degassed water. Wherever conversion of m (molality) 
to C (molarity) is required it has been done by using 







 … (1) 
 
In this equation m is the molality (mol kg
−1
) of 
solution, M2 is the molecular mass (kg mol
−1
) of 
doxycycline hyclate and ρ is the density (kg m
−3
) of 
solution. To calculate the viscosity of doxycycline 
hyclate in water, aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine following 











Where, ρs  (kg m
−3
), ts  (s), ηs  (milliPa s) are the 
density, flow time and viscosity of solution, 
respectively. The symbols ρo  (kg m
−3
), to(s) and ηo  
(milliPa s) are used to represent density, flow time 
and viscosity of the pure solvent, respectively.  
 
Results and Discussion  
Volumetric studies 
Apparent molar volume  𝑽𝝓 and partial molar volume (𝑽𝝓
𝒐 ) 
The apparent molar volume, Vϕ has been calculated 
with the help of density data, ρ for doxycycline hyclate 
in water, (0.002, 0.004 and 0.006) mol kg
-1
aqueous 
solution of L-phenylalanine and (0.002, 0.004 and 
Table 1 — Specifications of chemicals used with their structures 






Chemical Formula C22H24N2O8HCl ½H2O ½C2H6O C9H11NO2 C4H8N2O3 
CAS NO. 24390-14-5 63-91-2 556-50-3 






 aqueous solution of glycyl glycine at 










o   … (3) 
 
Where, mD  is the molality (mol kg
−1
) of the 




), ρ and ρo  are the density of solution and  
pure solvent (kg m
−3
), respectively. The values of 
density for doxycycline hyclate in water,  
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine are reported in  
Table 2. 
 
Table 2 — Values of density (ρ) and ultrasonic velocity (u) of doxycycline hyclate in water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine at different temperatures 
*mD (mol kg
-1) ρ x 10-3 (kg m-3) u (m s-1) 
















Doxycycline hyclate + water 
0.000 0.995044 0.993310 0.991417 0.989368 1511.00 1519.11 1528.98 1537.09 
0.002 0.995312 0.993569 0.991667 0.989610 1511.46 1519.58 1529.45 1537.57 
0.003 0.995444 0.993697 0.991791 0.989730 1511.70 1519.82 1529.70 1537.82 
0.004 0.995576 0.993824 0.991914 0.989848 1511.94 1520.06 1529.95 1538.07 
0.005 0.995706 0.993951 0.992036 0.989966 1512.18 1520.31 1530.20 1538.33 
0.006 0.995836 0.994076 0.992157 0.990083 1512.42 1520.56 1530.46 1538.58 
0.007 0.995965 0.994201 0.992278 0.990200 1512.67 1520.81 1530.72 1538.84 
0.008 0.996093 0.994326 0.992397 0.990316 1512.92 1521.06 1530.98 1539.10 
0.009 0.996219 0.994449 0.992516 0.990431 1513.17 1521.31 1531.24 1539.36 
0.010 0.996348 0.994572 0.992633 0.990544 1513.43 1521.57 1531.50 1539.62 
Doxycycline hyclate + 0.002 mol kg-1 L-phenylalanine 
0.000 0.995239 0.993568 0.991651 0.989550 1514.41 1525.45 1532.96 1539.88 
0.002 0.995507 0.993827 0.991901 0.989791 1514.87 1525.92 1533.44 1540.37 
0.003 0.995640 0.993955 0.992025 0.989910 1515.10 1526.16 1533.68 1540.62 
0.004 0.995772 0.994084 0.992148 0.990030 1515.34 1526.40 1533.93 1540.87 
0.005 0.995902 0.994211 0.992270 0.990149 1515.58 1526.65 1534.18 1541.12 
0.006 0.996034 0.994337 0.992392 0.990266 1515.83 1526.90 1534.43 1541.38 
0.007 0.996164 0.994462 0.992513 0.990384 1516.07 1527.15 1534.69 1541.64 
0.008 0.996295 0.994587 0.992633 0.990502 1516.32 1527.41 1534.95 1541.90 
0.009 0.996425 0.994711 0.992753 0.990618 1516.57 1527.67 1535.21 1542.17 
0.010 0.996554 0.994835 0.992872 0.990735 1516.82 1527.93 1535.48 1542.43 
Doxycycline hyclate + 0.004 mol kg-1 L-phenylalanine 
0.000 0.995309 0.993613 0.991715 0.989604 1514.49 1524.49 1532.99 1539.90 
0.002 0.995576 0.993871 0.991964 0.989843 1514.95 1524.96 1533.47 1540.38 
0.003 0.995708 0.993999 0.992087 0.989961 1515.18 1525.20 1533.71 1540.63 
0.004 0.995840 0.994126 0.992210 0.990079 1515.42 1525.44 1533.96 1540.88 
0.005 0.995971 0.994253 0.992332 0.990197 1515.66 1525.69 1534.21 1541.13 
0.006 0.996101 0.994379 0.992454 0.990315 1515.90 1525.93 1534.46 1541.39 
0.007 0.996230 0.994505 0.992576 0.990431 1516.15 1526.19 1534.71 1541.65 
0.008 0.996360 0.994629 0.992695 0.990547 1516.40 1526.44 1534.97 1541.91 
0.009 0.996488 0.994754 0.992815 0.990663 1516.66 1526.70 1535.23 1542.17 
0.010 0.996615 0.994877 0.992935 0.990778 1516.92 1526.96 1535.50 1542.44 
Doxycycline hyclate + 0.006 mol kg-1 L-phenylalanine 
0.000 0.995375 0.993679 0.991776 0.989690 1514.53 1524.56 1532.95 1539.97 
0.002 0.995639 0.993935 0.992022 0.989926 1514.99 1525.03 1533.43 1540.46 
0.003 0.995770 0.994062 0.992144 0.990043 1515.22 1525.27 1533.67 1540.71 
        (Contd.) 




Table 2 — Values of density (ρ) and ultrasonic velocity (u) of doxycycline hyclate in water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine at different temperatures (Contd.) 
*mD (mol kg
-1) ρ x 10-3 (kg m-3) u (m s-1) 
















0.004 0.995900 0.994188 0.992266 0.990160 1515.46 1525.51 1533.92 1540.96 
0.005 0.996030 0.994313 0.992387 0.990277 1515.71 1525.76 1534.17 1541.21 
0.006 0.996158 0.994438 0.992507 0.990393 1515.95 1526.01 1534.42 1541.47 
0.007 0.996286 0.994562 0.992626 0.990509 1516.21 1526.26 1534.68 1541.73 
0.008 0.996414 0.994680 0.992746 0.990625 1516.46 1526.53 1534.94 1541.98 
0.009 0.996541 0.994808 0.992865 0.990740 1516.72 1526.78 1535.20 1542.25 
0.010 0.996666 0.994930 0.992983 0.990855 1516.98 1527.05 1535.47 1542.52 
Doxycycline hyclate + 0.002 mol kg-1glycyl glycine 
0.000 0.995236 0.993565 0.991648 0.989548 1514.35 1524.20 1532.91 1539.8 
0.002 0.995500 0.993821 0.991894 0.989784 1514.87 1524.67 1533.39 1540.29 
0.003 0.995632 0.993948 0.992017 0.989902 1515.10 1524.91 1533.64 1540.54 
0.004 0.995762 0.994074 0.992139 0.990019 1515.34 1525.16 1533.89 1540.79 
0.005 0.995892 0.994200 0.992260 0.990136 1515.58 1525.41 1534.14 1541.04 
0.006 0.996021 0.994325 0.992380 0.990253 1515.83 1525.66 1534.39 1541.30 
0.007 0.996149 0.994450 0.992501 0.990369 1516.08 1525.91 1534.65 1541.56 
0.008 0.996276 0.994573 0.992619 0.990485 1516.33 1526.17 1534.91 1541.82 
0.009 0.996403 0.994696 0.992739 0.990600 1516.59 1526.43 1535.17 1542.08 
0.010 0.996530 0.994820 0.992857 0.990714 1516.84 1526.69 1535.44 1542.35 
Doxycycline hyclate + 0.004 mol kg-1glycyl glycine 
0.000 0.995306 0.993610 0.991713 0.989835 1514.40 1524.35 1532.92 1539.82 
0.002 0.995569 0.993864 0.991957 0.989835 1514.86 1524.82 1533.40 1540.31 
0.003 0.995699 0.993990 0.992078 0.989952 1515.10 1525.06 1533.64 1540.56 
0.004 0.995829 0.994116 0.992199 0.990068 1515.34 1525.31 1533.89 1540.81 
0.005 0.995957 0.994241 0.992319 0.990184 1515.58 1525.55 1534.14 1541.06 
0.006 0.996086 0.994365 0.992439 0.990299 1515.83 1525.80 1534.40 1541.32 
0.007 0.996212 0.994488 0.992559 0.990414 1516.08 1526.06 1534.65 1541.58 
0.008 0.996338 0.994612 0.992678 0.990529 1516.34 1526.32 1534.91 1541.84 
0.009 0.996463 0.994733 0.992796 0.990643 1516.59 1526.58 1535.18 1542.11 
0.010 0.996589 0.994855 0.992914 0.990757 1516.85 1526.85 1535.45 1542.38 
Doxycycline hyclate + 0.006 mol kg-1glycyl glycine 
0.000 0.995372 0.993676 0.991773 0.989687 1514.44 1524.40 1533.05 1539.91 
0.002 0.995633 0.993929 0.992016 0.989920 1514.90 1524.87 1533.53 1540.40 
0.003 0.995763 0.994054 0.992138 0.990036 1515.14 1525.11 1533.77 1540.65 
0.004 0.995892 0.994179 0.992258 0.990151 1515.38 1525.35 1534.02 1540.90 
0.005 0.996020 0.994303 0.992378 0.990267 1515.62 1525.60 1534.27 1541.15 
0.006 0.996147 0.994426 0.992497 0.990381 1515.87 1525.86 1534.53 1541.41 
0.007 0.996273 0.994549 0.992616 0.990496 1516.12 1526.11 1534.78 1541.67 
0.008 0.996399 0.994671 0.992734 0.990610 1516.38 1526.37 1535.05 1541.94 
0.009 0.996524 0.994793 0.992851 0.990724 1516.64 1526.63 1535.31 1542.20 
0.010 0.996649 0.994913 0.992968 0.990838 1516.90 1526.90 1535.58 1542.47 
*mD is the molality of doxycycline hyclate in water, aqueous solution of L-phenylalanine and aqueous solution of glycyl glycine 
Standard uncertainty (Q) in temperature is Q(T) = 0.05 K, molality Q(mD) = 3 x 10
-3mol kg-1, density is Q(ρ) = 3 x 10-3 kg m−3 and sound 
velocity is Q(u) = 6 x 10-1 m s-1 





The calculated values of apparent molar volume, Vϕ for 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine are 
given in Supplementary Data, Table S1. The sample plots 
showing the variation of Vϕ with mDare given in Fig. 1. 
The relation between partial molar volume (Vϕ
o) 
with molality (mD) is calculated by using Masson’s 
equation
32-33
 as below: 
Vϕ = Vϕ
o + SvmD …(4) 
 
Where, mD is the molality of the solution and Sv  is 
the experimental slope. The important information 
about solute-solvent interactions and solute-solute 
interactions is obtained from the values of Vϕ
oand Sv , 
respectively
34
. The values of  Vϕ




Fig. 1 — Plots of apparent molar volume (Vϕ) vs molality (mD) for doxycycline hyclate in (a) 0.002 mol kg
-1 aqueous solution of L-
phenylalanine, (b) 0.004 mol kg-1 aqueous solution of L-phenylalanine and (c) 0.006 mol kg-1 aqueous solution of L-phenylalanine at 
different temperatures 
 
Table 3 — Values of limiting apparent molar volume (Vϕ
o), experimental slope (Sv) and partial molar volume of transfer (Δtr Vϕ
o) of 
doxycycline hyclate in water, aqueous solution of L-phenylalanine and aqueous solution of glycyl glycine at different temperatures 
*mA (mol kg
-1) Vϕ
o  x 106 (m3 mol-1) Sv  x 10
6(kg m3 mol-2) 
 T=305.15 K T=310.15 K T=315.15 K T=320.15 K T=305.15 K T=310.15 K T=315.15 K T=320.15 K 




















































































































o  x 106 (m3 mol-1) 
 Doxycycline hyclate + aqueous solution of L-phenylalanine  Doxycycline hyclate + aqueous solution of glycyl glycine 
0.002 
0.004 
0.07 0.04 0.28 0.80 1.50 1.72 2.26 3.32 
0.23 0.69 0.99 1.87 2.08 2.63 3.61 4.29 
0.006 1.65 1.52 2.41 3.46 2.99 3.22 3.71 4.94 
*mA is the molality of L-phenylalanine in water and glycyl glycine in water. Standard uncertainty (Q) in molality Q(mA)  
= 2 x 10-3mol kg-1 
The values in brackets represent standard errors 




The positive values of  Vϕ
o  and Sv  for doxycycline 
hyclate in different solvent systems indicate the 
presence of significant solute-solvent interactions. 
However the larger magnitude of  Vϕ
o  than Sv  imply 
more effective solute-solvent interactions than solute-
solute interactions for doxycycline hyclate in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine
9,25
. The values of  Vϕ
o  for 
doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl 
glycine increases in the following order: 
Water<aqueous solution of L-phenylalanine 
<aqueous solution of glycyl glycine 
This order indicates that solute-solvent interactions 
increase in the same order and these interactions are 
most operative in aqueous solution of glycyl glycine. 
Similar trends have been investigated for drug 




It is also observed that the values of  Vϕ
o  increase 
with the increase in concentration of L-phenylalanine 
and glycyl glycine for doxycycline hyclate in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine at all temperatures. This 
specifies that drug-solvent interactions increase with 
the increase in concentration of L-phenylalanine and 
glycyl glycine. The values of  Vϕ
o for doxycycline 
hyclate in water, aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine also increase 
with the increase in temperature
4
. The variation of Vϕ
o  
with T is shown in Fig. 2. 
 
Partial molar volume of transfer (𝜟𝒕𝒓𝑽𝝓
𝒐 ) 
The partial molar volume of transfer (Δtr Vϕ
o ) is the 
transfer volume of doxycycline hyclate from water to 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine. It supplies useful 
information about the kind of interactions occurring 
between solute and pure solvent molecules because 
interactions amongst solute molecules are minimal at 
infinite dilution
4,32
. The partial molar volume of 








o aqs L − phenylalanine or glycyl glycine −
Vϕ
o (water)  … (5) 
 
The values of partial molar volume of transfer 
obtained from Eqn (5) are tabulated in Table 3. The 
values of Δtr Vϕ
o are positive and magnitude  
increases with the increase in concentration of L-
phenylalanine and glycyl glycine. The possible 
interactions for doxycycline hyclate in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine may be explained as follows. 
The ion-ion interactions are possible when 
carboxylate ion and ammonium ion of L-
phenylalanine and glycyl glycine, interacts with the 
ionic part of doxycycline hyclate. The ion-hydrophilic 
interactions are possible when carboxylate ion and 
ammonium ion of L-phenylalanine and glycyl 
glycine, interacts with the polar part of doxycycline 
hyclate. The ion-hydrophobic interactions occur due 
to the overlapping of co-spheres of ionic part (zwitter-
ions) of L-phenylalanine and glycyl glycine, and co-
spheres of non-polar part of doxycycline hyclate. The 
hydrophobic-hydrophobic interactions result due to 
the overlap of co-spheres of non-polar part of L-
phenylalanine and glycyl glycine, and non-polar part 
of doxycycline hyclate. 
 
Fig. 2 — Plots of partial molar volume (Vϕ
o) vs temperature (T) for doxycycline hyclate in (a) water and (0.002, 0.004 and 0.006) mol kg-1 
aqueous solution of L-phenylalanine and (b) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous solution of glycyl glycine 




As stated by co-sphere overlap model
38-41
, the 
interactions resulting from the overlap of ionic and 
hydrophilic groups contributes positively to Δtr Vϕ
o  
and those involving hydrophobic groups contribute 
negatively to transfer volume
35-37
. The positive values 
of Δtr Vϕ
o  for doxycycline hyclate in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine indicate the presence of ion-ion group 
interactions as well as ion-hydrophilic group 
interactions between zwitter ionic center of amino 
acids and charged or polar groups of drug 
molecules
5,8
. The larger values of transfer volume in 
aqueous solution of glycyl glycine than in aqueous 
solution of L-phenylalanine may be due to more 
operative interactions between zwitter ionic 
center/polar peptide bond of glycyl glycine with the 
charged/polar groups of drug. However, the benzyl 
group in L-phenylalanine hinders the zwitter ionic 
group of amino acid and other interacting groups of 
drug. Thus smaller values of Δtr Vϕ
o  for doxycycline 
hyclate in aqueous solution of L-phenylalanine may 
be due to the less effective ion-hydrophilic 
interactions between hindered zwitter ion of L-
phenylalanine and charged/polar groups of drug. The 
positive values of Δtr Vϕ
o  also indicate the structure 
maker nature of doxycycline hyclate in aqueous 
solution of glycyl glycine and L-phenylalanine
22-26
. 
The increase in transfer volume with the increase in 
concentration of L-phenylalanine and glycyl glycine 
may be due to the enhanced ion-ion and ion-
hydrophilic group interactions with the increase in 
concentration of L-phenylalanine and glycyl glycine. 
However, the increase in transfer volume with the rise 
in temperature is attributed to the increase in thermal 
agitation which causes breaking of bonds. 
 
Partial molar expansibility (𝑬𝝓
𝒐 ), isobaric thermal expansion 
coefficient (αo) and Hepler’s constant (2c) 




 has been used to calculate the partial 
molar expansibility (Eϕ
o) for doxycycline hyclate in 
water, aqueous solution of L-phenylalanine and 











= b + 2 c T … (6) 
 
In this equation, Vϕ
o =  a +  b T +  c T2 where T is 
the temperature in Kelvin and the constants a, b and c 
are calculated by solving this equation at different 
temperatures. The values of constants a, b and c are 
shown in Table 4. 
Table 4 — Values of partial molar expansibility (Eϕ
o ), isobaric thermal expansion coefficient (αo) at different temperatures,  
empirical parameters, a, b, c and Hepler’s constant (2c) for doxycycline hyclate in water, aqueous solution of L-phenylalanine  
and aqueous solution of glycyl glycine 
*mA (mol kg
-1) Eϕ
o  x 106 (m3 mol-1 K-1) 
 
 Doxycycline hyclate + aqueous solution of L-phenylalanine  Doxycycline hyclate + aqueous solution of glycyl glycine 
 T=305.15 K T=310.15 K T=315.15 K T=320.15 K T=305.15 K T=310.15 K T=315.15 K T=320.15 K 
0.000 0.88 0.94 1.01 1.07 0.88 0.94 1.01 1.07 
0.002 0.01 0.11 0.21 0.31 0.42 0.52 0.62 0.72 
0.004 0.13 0.23 0.33 0.43 0.44 0.54 0.64 0.74 
0.006 0.70 1.00 1.30 1.60 0.96 1.06 1.16 1.26 
αo  (K-1) 
0.000 0.23 0.25 0.26 0.27 0.23 0.25 0.26 0.27 
0.002 0.03 0.29 0.55 0.79 1.11 1.35 1.59 1.82 
0.004 0.35 0.61 0.85 1.09 1.16 1.40 1.64 1.87 
0.006 1.83 2.59 3.32 4.02 2.52 2.74 2.96 3.17 
 a x 106 
(m3 mol-1) 
b x 106 
(m3 mol-1 K-1) 
c x 106 
(m3 mol-1 K-2) 
2c x 106 
(m3 mol-1 K-2) 
a x 106 
(m3 mol-1) 
b x 106 
(m3 mol-1 K-1) 
c x 106 
(m3 mol-1 K-2) 
2c x 106 
(m3 mol-1 K-2) 
 Doxycycline hyclate +aqueous solution of L-phenylalanine  Doxycycline hyclate + aqueous solution of glycyl glycine 
0.000 698.16 -2.97 0.01 0.02 698.16 -2.97 0.01 0.02 
0.002 1298.78 -6.09 0.01 0.02 1108.81 -5.68 0.01 0.02 
0.004 539.93 -5.97 0.01 0.02 1325.64 -5.66 0.01 0.02 
0.006 1648.82 -17.61 0.03 0.06 1028.72 -5.14 0.01 0.02 
*mA is the molality of L-phenylalanine in water and glycyl glycine in water. Standard uncertainty (Q) in molality Q(mA) =  
2 x 10-3mol kg-1 




The values of partial molar expansibility (Eϕ
o) have 
been used to derive important conclusions about 




values show a rising trend with the increase in 
temperature (Fig. 3) which predicts the presence of 
‘caging effect’
49
. The isobaric thermal expansion 
coefficient (α
o
) can also be used as a supportive 
parameter to study structure maker/breaker behavior of 
doxycycline hyclate in water, (0.002, 0.004 and 0.006) 
mol kg
−1
aqueous solution of L-phenylalanine and 
(0.002, 0.004 and 0.006) mol kg
−1
aqueous solution of 
glycyl glycine. It is the ratio of partial molar adiabatic 
expansibility (Eϕ
o) to partial molar volume (Vϕ
o) i.e.  
 




o  … (7) 
 
The rising trend of α
o
 with the increase in 
temperature (Fig. 4) predicts the structure promoter 
nature of doxycycline hyclate in water, (0.002, 0.004 
and 0.006) mol kg
−1
 aqueous solution of  
L-phenylalanine and (0.002, 0.004 and 0.006)  
mol kg
−1





calculated using Eqn (7) have been shown 
in Table 4. 
The structure making and breaking ability of 
doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl 






)P devised by Hepler
47











 = 2c … (8) 
 
The positive sign of Hepler’s constant
23,51
 signifies 
structure making behavior of solute and negative sign 
of Hepler’s constant signifies structure breaking 
behaviour of solute
52-53
. Thus positive sign of Hepler’s 
constant indicates structure making behaviour of 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine. 
The calculated values of Hepler’s constant are 
recorded in Table 4. 
 
 
Fig. 3 — Plots of partial molar expansibility(Eϕ
o ) vs temperature (T) for doxycycline hyclate in (a) water and (0.002, 0.004 and 0.006) 
mol kg-1 aqueous solution of L-phenylalanineand (b) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous solution of glycyl glycine 
 
 
Fig. 4 — Plots of isobaric thermal expansion coefficient(αo) vs temperature (T) for doxycycline hyclate in (a) water and (0.002, 0.004 
and 0.006) mol kg-1 aqueous solution of L-phenylalanine and (b) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous solution of glycyl 
glycine 





Adiabatic compressibility (𝜿𝒔) and apparent molar adiabatic 
compressibility (𝜿𝝓,𝒔) 
The adiabatic compressibility is defined as the 
fractional decline of volume per unit pressure, when 















 for calculating 
adiabatic compressibility by using sound velocity and 
density data is given as, 
 
κs









In Eqn (10) κs
o  and κs  are the isentropic 
compressibility of pure solvent and solution. Symbols 
ρoand ρ are used for the density (kg m
−3
) of pure 
solvent and solution, respectively. The ultrasonic 
velocity of the pure solvent and solution are denoted 
by uo and u, respectively. The values of sound 
velocity are given in Table 2. 
The data related to κsfor doxycycline hyclate in 
water, aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine has been shown in 
Supplementary Data, Table S2. From the data it is clear 
that the values of κs  decrease with the increase in 
concentration of drug and amino acids as well. The 
values of adiabatic compressibility also show a declining 
trend with the rise in temperature. Same trends have 
been observed for glycine and DL-alanine in aqueous 
furosemide solutions at different temperatures
23
.  
The values of κs  and κs
o  can be used to calculate 
the apparent molar adiabatic compressibility, κϕ,s  for 
doxycycline hyclate in water, (0.002, 0.004 and 
0.006) mol kg
−1
aqueous solution of L-phenylalanine 











 … (11) 
 
Where mD  is the molality (mol kg
−1
) of the 
solution, M2 is the molar mass of the solute (kg 
mol
−1
), ρo  and ρ are the density (kg m
−3
) of pure 
solvent and solution, respectively, κs
oand κs  are the 
isentropic compressibility of pure solvent and 
solution, respectively. The κϕ,s values for doxycycline 
hyclate in water, aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine have been 
given in Supplementary Data, Table S1. The negative 
magnitude of κϕ,s  for doxycycline hyclate in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine at different temperatures 
indicate that water molecules around the solute are 
less compressible than those present in the bulk 
specifying the presence of significant solute-solvent 
interactions
17,26
. The magnitude of κϕ,s is found to 
decrease with the increase in concentration of Center 
L-phenylalanine or glycyl glycine and temperature. 
 
Partial molar isentropic compressibility (𝜿𝝓,𝒔
𝒐 ) and partial molar 
isentropic compressibility of transfer (𝜟𝒕𝒓𝜿𝝓,𝒔
𝒐 ) 






o + SkmD  … (12) 
 
In the above equation intercept (κϕ,s
o ) is known as 
partial molar isentropic compressibility and furnishes 
information about solute-solvent interaction
56
 however 
experimental slope (Sk) represents solute-solute 
interactions which are insignificant at infinite dilution. 
Thus solute-solvent interactions are predominant over 
solute-solute interactions in solutions at infinite 
dilution
17,26
. The sample κϕ,s  vs mD  curves are shown in 
Fig. 5 and plots are found to be almost linear. 
 
Fig. 5 — Plots of apparent molar isentropic compressibility (κϕ,s) vs molality (mD) for doxycycline hyclate in (a) 0.002 mol kg
-1 aqueous 
solution of L-phenylalanine, (b) 0.004 mol kg-1 aqueous solution of L-phenylalanine and (c) 0.006 mol kg-1 aqueous solution of  
0.L-phenylalanine at different temperatures 





o  values along with Sk values for 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine 
are tabulated in Table 5.The negative values of κϕ,s
o  
for doxycycline hyclate in water, aqueous solution of 
L-phenylalanine and aqueous solution of glycyl 
glycine indicate the presence of solute-solvent 
interactions. The values κϕ,s
o  for doxycycline hyclate 
in water are more negative than the corresponding 
values in water, aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine. The presence 
of attractive interactions between drug and water 
molecules account for the more negative values of 
κϕ,s
o  for doxycycline hyclate in water. The smaller 
negative κϕ,s
o  values in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine 
indicate the decline in electrostriction in the ternary 
systems (doxycycline hyclate + L-phenylalanine or 
glycyl glycine + water). The effective interactions 
between drug and L-phenylalanine or glycyl glycine 
in the ternary systems induce the dehydration of  
L-phenylalanine or glycyl glycine.This increases 
water molecules in bulk and increases the 
compressibility of the solution. The values of κϕ,s
o  
become less negative with the increase in 
concentration of L-phenylalanine and glycyl glycine. 
This is due to more effective drug-amino acid or 
dipeptide interactions which induces dehydration  
of amino acids at higher concentration of L-
phenylalanine and glycyl glycine
17,26,57
. The results 
for L-glutamine and L-histidine in aqueous solutions 
of metformin hydrochloride also support the 
observed conclusions
22
. However, due to increase in 
temperature there is increase in thermal agitation 
which declines electrostriction
11,48,50
. This causes 
increase in compressibility of the solution with the 
increase in temperature. The variation of κϕ,s
o  with T 
is shown in Fig. 6. 
The partial molar isentropic compressibility of 
transfer, Δtr κϕ,S
o  is calculated by using the relation, 
Table 5 — Values of partial molar isentropic compressibility (κϕ,s
o ), experimental slope (Sk) and partial molar isentropic compressibility 
of transfer (Δtrκϕ,s




o  x 1014(m3 mol-1 Pa-1) Sk  x 10
14 (kg m3 mol-1 Pa-1) 
 T=305.15 K T=310.15 K T=315.15 K T=320.15 K T=305.15 K T=310.15 K T=315.15 K T=320.15 K 




















































































































o  x 1014(m3 mol-1 Pa-1) 
 Doxycycline hyclate +aqueous solution of L-phenylalanine  Doxycycline hyclate +aqueous solution of glycyl glycine 
0.002 0.21 0.20 0.13 0.01 0.25 0.23 0.18 0.14 
0.004 0.28 0.22 0.16 0.15 0.35 0.32 0.30 0.25 
0.006 0.44 0.34 0.32 0.16 0.53 0.52 0.46 0.32 
*mA is the molality of L-phenylalanine in water and glycyl glycine in water. Standard uncertainty (Q) in molality Q(mA)  
= 2 x 10-3mol kg-1 
The values in brackets represent standard errors 






o  aqs L − phenylalanine  or glycyl glycine −
κϕ,s
o  (water) … (13) 
The values of partial molar isentropic 
compressibility of transfer, Δtr κϕ,s
o  in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine are positive at different temperatures 
and are given in Table 5. 
The positive Δtr κϕ,s
o  values for doxycycline hyctate 
in water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine specify influence 
of charged end and polar groups. The negative values 
of Δtr κϕ,s
o  are attributed to the influence of 
hydrophobic groups
17,26
. In the present study the 
positive values of Δtr κϕ,S
o  for doxycycline hyclate in 
water, aqueous solution of L-phenylalanine and 
aqueous solution of glycyl glycine are attributed to 
the existence of ion-ion and ion-hydrophilic 
interactions between zwitter ionic center of Center  
L-phenylalanine or glycyl glycine and charged groups 
of doxycycline hyclate. The values of Δtr κϕ,s
o  are 
higher in aqueous solution of glycyl glycine than in 
aqueous solution of L-phenylalanine which indicates 
strong ion-hydrophilic interactions in aqueous 
solution of glycyl glycine than in aqueous solution of 
L-phenylalanine. This is attributed to more effective 
interactions between zwitter ionic center/polar peptide 
bond of glycyl glycine with the charged groups of 
doxycycline hyclate. However in L-phenylalanine the 
benzyl group hinders the zwitter ionic center and thus 
leads to less effective interactions of zwitter ion of  
L-phenylalanine with the charged groups of drug.  
The increase in the values of Δtr κϕ,s
o  with the rise in 
concentration of L-phenylalanine and glycyl glycine 
suggests that electrostriction decreases and structure 
making tendency of doxycycline hyclate increases 
with the increase in concentration of L-phenylalanine 
and glycyl glycine
17,26,57
. This may be due to increase 
in interactions between zwitter ionic center of L-
phenylalanine and glycyl glycine, and charged groups 
of doxycycline hyclate with the increase in 
concentration of L-phenylalanine and glycyl glycine. 
 
Intermolecular free length (Lf) and acoustic impedance (Z) 
Jacobson assumed the liquid molecules are 
spherical and the average distance that ultrasonic 
waves traverse between two molecules is called 
intermolecular free length. This theory is known as 
Jacobson’s intermolecular free length theory for 
liquids
58
. The intermolecular free length according to 






 … (14) 
 
Where, KT is the temperature dependent constant  




. The decrease in 
intermolecular free length at higher concentration of 
drug in water, aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine predicts the 
presence of significant solute-solvent interactions 
which bring the molecules closer.  
The specific acoustic impedance is the supporting 
parameter used to determine the obstruction offered 
by the medium for the transmission of sound waves 
through it. The specific acoustic impedance is 




Z =  u ρ … (15) 
 
Where, u is the sound velocity (m s
−1
) and ρ is  
the density (kg m
−3
) of liquid, respectively. The data 
 
Fig. 6 — Plots of partial molar isentropic compressibility (κϕ,s
o ) vs temperature (T) for doxycycline hyclate in (a) water and (0.002,  
0.004 and 0.006) mol kg-1 aqueous solution of L-phenylalanine and (b) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous solution of 
glycyl glycine 
 




related to Lf  and Z has been reported in 
Supplementary Data, Table S2. 
Both sound velocity and density of solution are 
highly temperature dependent therefore acoustic 
impedance varies directly with temperature. The rise 
in acoustic impedance values with the rise in 
concentration of drug and temperature indicates  
the presence of bulkier/solvated molecules. This 
predicts the presence of significant solute-solvent 






The values of viscosity derived from Eqn (2) have 
been found to increase with the increase in 
concentration of doxycycline hyclate as well as L-
phenylalanine and glycyl glycine. This may bedue to 
the increase in accessibility of charged molecules of 
drug and zwitterions of Center L-phenylalanine or 
glycyl glycine for interactions with the rise in 
concentration of doxycycline hyclate and Center L-
phenylalanine or glycyl glycine. The strengthening of 
intermolecular interactions increase the frictional 
resistance, this causes an increase in the viscosity of 
different solutions. However, with the increase in 
temperature, the movements of interacting molecules 
in solutions become faster. This increases the kinetic 
energy of molecules and thus favours the decrease in 
viscosity with the increase in temperature
60-61
. The 
values of viscosity have been reported in 
Supplementary Data, Table S3. 
The Jones-Dole Eqn
62
 which gives the variation of 
Ѱ =  
(ηr− 1)
C1/2
 with C1/2 is represented as: 
 
Ѱ =  
(ηr− 1)
C1/2
 =  A + B C1/2 … (16) 
 










is the viscosity of solution and 
pure solvent, respectively and C is the molarity (mol 
m
−3
) of the solution. The sample graphs showing the 
variation of Ѱ vs C1/2 are plotted in Fig. 7. The values 
of Ѱ have been tabulated in Supplementary Data, 
Table S3. The Falkenhagen coefficient i.e. intercept A 
is the symbolic of solute-solute interactions and 




The positive values of B-coefficient indicate the 
presence of solute-solvent interactions in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine
64
. On comparing the magnitude of  
B-coefficient in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine, it 
has been found that values increase in the following order, 
Water<aqueous solution of L-phenylalanine 
<aqueous solution of glycyl glycine 
This trend of B-coefficient values indicate that 
solute-solvent interactions increase in the same order. 
The larger positive B-coefficient for doxycycline 
hyclatein water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl 
glycine values also indicate the presence of more 
pronounced ion-hydrophilic interactions in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine. The increase in  
ion-hydrophilic interactions in the presence of  
L-phenylalanine and glycyl glycine may be due to 
more operative interactions between zwitter ionic 
center and charged groups of drug in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine. It is also noticed that as the 
concentration of L-phenylalanine and glycyl glycine 
 
Fig. 7 — Plots ofѰ =  
(ηr− 1)
C1/2
 vs concentration (C1/2) for doxycycline hyclate in (a) 0.002 mol kg-1 aqueous solution of L-phenylalanine, 
(b) 0.004 mol kg-1 aqueous solution of L-phenylalanine and (c) 0.006 mol kg-1 aqueous solution of L-phenylalanine at different 
temperatures 




increases from 0.002 to 0.006 mol kg
−1
, the magnitude 
of B-coefficient also increases. This indicates the 
strengthening of ion-hydrophilic interactions with the 
increase in concentration of L-phenylalanine and 
glycyl glycine.  
The structure maker and breaker behaviour of 
doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl 




. The negative values of 
dB
dT
 in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine infers structure maker ability of 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine. 
The values of 
dB
dT
 along with B-coefficient have been 




 . The results are similar to the 
results obtained by Kaur and Kumar in their study of 
amino acids in ampicillin and amoxicillin
61
. 
The Δtr B is the viscosity B-coefficient of transfer 
from water to aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine and has been 




Δtr B =  B  aqs L − phenylalanine or glycyl glycine −
B (water) …(17) 
 
The values are tabulated in Table 6. The larger 
positive values of Δtr B interprets that the  
ion-hydrophilic interactions are overpowering  
theion-hydrophobic interactions. The values Δtr B for 
doxycycline hyclate in water, aqueous solution of  
Table 6 — Values of B-coefficient, Δtr B (at different temperatures) and 
dB
dT
 of doxycycline hyclate in water, aqueous solution of  
L-phenylalanine and aqueous solution of glycyl glycine 
B x 103 (mol-1 m3) 
Temperature (K) Doxycycline 
hyclate in water 
Doxycycline hyclate in aqueous 
solution of L-phenylalanine 
Doxycycline hyclate in aqueous solution  
of glycyl glycine 
  0.002 mol kg-1 0.004 mol kg-1 0.006 mol kg-1 0.002 mol kg-1 0.004 mol kg-1 0.006 mol kg-1 
305.15 0.169 0.177 0.180 0.183 0.201 0.204 0.206 
310.15 0.146 0.149 0.151 0.156 0.176 0.180 0.181 
315.15 0.125 0.127 0.128 0.130 0.153 0.158 0.159 
320.15 0.101 0.102 0.103 0.105 0.128 0.129 0.133 
Δtr B x 10
3 (mol-1 m3) 
305.15 --- 0.008 0.011 0.014 0.032 0.035 0.037 
310.15 --- 0.003 0.005 0.010 0.030 0.034 0.035 
315.15 --- 0.002 0.003 0.005 0.028 0.033 0.034 
320.15 --- 0.001 0.002 0.004 0.027 0.028 0.032 
dB
dT
 x 103 (mol-1 m3 K-1) 
 -0.005 -0.005 -0.005 -0.005 -0.005 -0.005 -0.005 
Standard uncertainty (Q) in temperature is Q(T) = 0.05 K 
 
 
Fig. 8 — Plots of B-coefficient vs temperature (T) for doxycycline hyclate in (a) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous 
solution of L-phenylalanine, (b) water and (0.002, 0.004 and 0.006) mol kg-1 aqueous solution of glycyl glycine 




L-phenylalanine and aqueous solution of glycyl 
glycine has the order 
Aqueous solution of L-phenylalanine<aqueous 
solution of glycyl glycine 
The smaller Δtr B  values in aqueous solution of  
L-phenylalanine are attributed to the benzyl group 
which due to its large size hinders the zwitter ionic 
center of L-phenylalanine and interacting groups of 
drug. Thus, makes the ion-hydrophilic interactions 
less effective in aqueous solution of L-phenylalanine. 
The largerΔtr Bvalues in aqueous solution of glycyl 
glycine are due to effective interactions of zwitter 
ionic center as well as polar peptide bond with the 
charged groups of doxycycline hyclate. The larger 
positive Δtr B values also indicate enhanced structural 
order in aqueous solution of glycyl glycine than in 
aqueous L-phenylalanine. Moreover the rising trend 
shown by Δtr B with the increase in concentrations of 
L-phenylalanine and glycyl glycine infers more 
effective ion-hydrophilic interactions and structural 
order is enhanced at higher concentrations of L-
phenylalanine and glycyl glycine. 
 





o∗ are the 
thermodynamic activation parameters of viscous flow, 
where Δμ
1
o∗ is the free energy of activation of viscous 
flow per mole of pure solvent and Δμ
2
o∗ is the free 
energy of activation of viscous flow per mole of solute. 
Eyring and co-workers
67
 put forward an expression for 
calculating Δμ
1
o∗by using Planck’s constant (h), 
Avogadro’s number (NA ), universal gas constant (R), 
temperature (T) and partial molar volume of the pure 
solvent (V1








) … (18) 
 
In Eqn (18) V1
o=∑
x i . M i
d
, where xi  and Mi are the 
mole fractions and molecular weights of pure solvent 
systems, respectively andd denotes the density of pure 
solvent systems.  
Feakins et al.,
29,38 
used Eyring transition state 
theory
67
 to calculate Δμ
2
o∗ and gave an expression 




o∗ =  Δμ
1









o , the partial molar volume of 
solute. The data is given in Table 7. The values of 
Δμ
2
o∗ are positive and observed to be much larger than 
the values of Δμ
1
o∗ for doxycycline hyclate in water, 
aqueous solution of L-phenylalanine and aqueous 
solution of glycyl glycine. This specifies that the 
interactions occurring indifferent solutions are more 
effective in ground state than in the transition state. 
This is conceivable when the intermolecular bonds 
deform and break in the transition state. On keen 
examination it is found that values of Δμ
2
o∗ increase in 
the order, 
Water<aqueous solution of L-phenylalanine<aqueous 
solution of glycyl glycine 
This order specifies that the ion-hydrophilic 
interactions of doxycycline hyclate with the 
respective groups also increase from water to aqueous 
solution of L-phenylalanine and to aqueous solution 
of glycyl glycine. The higher values of Δμ
2
o∗ for 
doxycycline hyclatein water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine 
than those in water indicate the enhanced ion-
hydrophilic interactions in the presence of L-
phenylalanine and glycyl glycine, This is due to the 
presence of zwitter ionic center in L-phenylalanine 
and glycyl glycine which interacts more effectively 
with the charged groups of doxycycline hyclate. 
Furthermore the smaller values of Δμ
2
o∗ for 
doxycycline hyclate in aqueous solution of L-
phenylalanine are due to the presence of bulky benzyl 
group in L-phenylalanine which produces hindrance 
to the interacting groups and larger values of Δμ
2
o∗in 
aqueous solution of glycyl glycine are due to the 
effective interactions of zwitter ionic/polar peptide 
bond of glycyl glycine with the charged groups of 
doxycycline hyclate. The large positive Δμ
2
o∗ values 
also infer structure maker nature of doxycycline 
hyclate which get enhanced in the above mentioned 
order i.e. water<L-phenylalanine<glycyl glycine. The 
Δμ
2
o∗ values increase with the rise in concentration of 
L-phenylalanine and glycyl glycine which suggests 
the enhanced ion-hydrophilic interactions with the 
rise in concentration of L-phenylalanine and glycyl 
glycine. 
The linear plots of Δμ
2
o∗ vs T for doxycycline 
hyclate in water as well as aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine 
(Fig. 9) are used to obtain the values of activation 
entropy (ΔS2
o∗). The activation entropy is represented 





 =  −ΔS2
o∗ … (20) 




The values of activation entropy (ΔS2
o∗) and free 
energy of activation of viscous flow per mole of 
solute (Δμ
2
o∗) have been used to calculate the 
activation enthalpy (ΔH2
o∗) for viscous flow of 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine. 
The relation is given as below: 
 
ΔH2
o∗ =  T ΔS2
o∗ − Δμ
2
o∗ … (21) 
The data of T ΔS2
o∗ and ΔH2
o∗ is given in Table 7. 
The information about stability of transition state is 
obtained from these parameters. The positive T ΔS2
o∗ 
values for doxycycline hyclate in water, aqueous 
solution of L-phenylalanine and aqueous solution of 
glycyl glycine indicate that very disordered transition 
state is formed. The positive ΔH2
o∗values also infer 
that intermolecular bond breaking in the transition 
state prevents the formation of activated complex and 




o∗ , T ΔS2
o∗ and ΔH2
o∗of doxycycline hyclate in water, aqueous solution of L-phenylalanine and 




o  x 106  
(m3 mol-1) 
V2














Doxycycline hyclate in water 
305.15 18.130 379.721 9.001 83.263 112.600 195.863 
310.15 18.189 384.271 8.901 81.475 114.445 195.920 
315.15 18.321 389.136 8.817 79.704 116.290 195.994 
320.15 18.413 394.084 8.733 77.698 118.135 195.833 
Doxycycline hyclate in 0.002 mol kg-1 L-phenylalanine 
305.15 18.086 379.794 9.011 84.549 115.957 200.506 
310.15 18.117 384.312 8.912 82.248 117.857 200.105 
315.15 18.152 389.423 8.829 80.732 119.757 200.489 
320.15 18.190 394.884 8.731 78.725 121.657 200.382 
Doxycycline hyclate in 0.004 mol kg-1 L-phenylalanine 
305.15 18.085 379.946 9.020 85.086 120.229 205.315 
310.15 18.116 384.960 8.920 82.580 122.199 204.779 
315.15 18.150 390.130 8.837 81.016 124.169 205.185 
320.15 18.185 395.952 8.751 79.045 126.139 205.184 
Doxycycline hyclate in 0.006 mol kg-1 L-phenylalanine 
305.15 18.084 381.365 9.027 85.701 124.196 209.897 
310.15 18.115 385.791 8.927 83.514 126.231 209.745 
315.15 18.149 391.546 8.846 81.506 128.266 209.772 
320.15 18.188 397.545 8.755 79.581 130.301 209.882 
Doxycycline hyclate in 0.002 mol kg-1glycyl glycine 
305.15 18.086 381.222 9.033 88.147 103.446 191.593 
310.15 18.117 385.995 8.924 86.364 105.141 191.505 
315.15 18.152 391.402 8.841 84.787 106.836 191.623 
320.15 18.190 397.395 8.756 83.016 108.531 191.547 
Doxycycline hyclate in 0.004 mol kg-1glycyl glycine 
305.15 18.085 381.803 9.033 88.712 108.023 196.735 
310.15 18.116 386.901 8.932 87.005 109.793 196.798 
315.15 18.150 392.748 8.848 85.725 111.563 197.288 
320.15 18.189 398.369 8.764 83.233 113.333 196.566 
Doxycycline hyclate in 0.006 mol kg-1glycyl glycine 
305.15 18.084 382.710 9.039 89.141 108.328 197.469 
310.15 18.115 387.487 8.942 87.330 110.103 197.433 
315.15 18.149 392.847 8.857 85.840 111.878 197.718 
320.15 18.188 399.021 8.775 83.970 113.653 197.623 
Standard uncertainty (Q) in temperature is Q(T) = 0.05 K 




thus favours the existence of stronger solute-solvent 
interactions in the ground state than in the transition 
state. The obtained results are also supported by the 
results for different amino acids in furosemide
66
. The 
comparison has shown that the values of T ΔS2
o∗ and 
ΔH2
o∗ decrease in the order
68-69
: 
Aqueous solution of L-phenylalanine>aqueous 
solution of glycyl glycine 
This order indicates that on moving from L-
phenylalanine to aqueous solution of glycyl glycine, 
the difficulty in the formation of activated complex 
increases and the ion-hydrophilic interactions also 
increase from aqueous solution of L-phenylalanine to 
aqueous solution of glycyl glycine. The less effective 
interactions in aqueous solution of L-phenylalanine 
are due to hindrance produced by bulky benzyl group 
to the interacting groups and strong interactions in 
aqueous solution of glycyl glycine are due to the 
effective interactions of zwitter ionic and polar 
peptide bond of glycyl glycine with the charged 
groups of doxycycline hyclate. 
 
Conclusions 
In the present study the behaviour of doxycycline 
hyclate has been studied in water, (0.002, 0.004 and 
0.006) mol kg
−1
aqueous solution of L-phenylalanine 
and aqueous solution of glycyl glycine by using 
volumetric, ultrasonic and viscosity parameters. The 
presence of significant solute-solvent interactions is 
indicated by parameters like partial molar volume, 
partial molar adiabatic compressibility, intermolecular 
free length, acoustic impedance and viscosity B-
coefficient. The study of transfer parameters reveals 
that ion-ion and ion-hydrophilic interactions are 
predominant over hydrophobic-hydrophobic 
interactions in water, L-phenylalanine and glycyl 
glycine at different temperatures. The comparative 
study has also indicated that the ion-hydrophilic 
interactions are more pronounced in aqueous solution 
of glycyl glycine than in aqueous solution of L-





infer that more energy is required for the formation of 
transition state and thus favour the strong 
intermolecular bond formation in the ground state 
than in transition state. This is further supported by 
positive magnitude of T ΔS2
o∗ and ΔH2
o∗ which 
indicate distortion of intermolecular bonds in the 
transition state. The increase in partial molar 
expansibility with temperature indicates the presence 
of caging effect. The structure maker behaviour of 
doxycycline hyclate in water, aqueous solution of L-
phenylalanine and aqueous solution of glycyl glycine 
is inferred from positive values of Hepler’s constant, 
negative magnitude of 
dB
dT
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